FR3110402B1 - Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera - Google Patents

Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera Download PDF

Info

Publication number
FR3110402B1
FR3110402B1 FR2005179A FR2005179A FR3110402B1 FR 3110402 B1 FR3110402 B1 FR 3110402B1 FR 2005179 A FR2005179 A FR 2005179A FR 2005179 A FR2005179 A FR 2005179A FR 3110402 B1 FR3110402 B1 FR 3110402B1
Authority
FR
France
Prior art keywords
protein extract
moringa oleifera
cosmetic use
oleifera seeds
oiled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2005179A
Other languages
English (en)
Other versions
FR3110402A1 (fr
Inventor
Christine Jeanmaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR2005179A priority Critical patent/FR3110402B1/fr
Priority to PCT/FR2021/050899 priority patent/WO2021234301A1/fr
Priority to JP2022570606A priority patent/JP2023527160A/ja
Priority to CN202180036930.0A priority patent/CN115697367A/zh
Publication of FR3110402A1 publication Critical patent/FR3110402A1/fr
Application granted granted Critical
Publication of FR3110402B1 publication Critical patent/FR3110402B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UTILISATION COSMETIQUE D’UN EXTRAIT PROTEIQUE DES GRAINES DE MORINGA OLEIFERA La présente invention concerne l’utilisation d’un extrait protéique de graine non germée déshuilée de Moringa oleifera comme agent anti-pollens. Elle concerne de plus l’extrait protéique de graine non germée déshuilée de Moringa oleifera, pour son utilisation dans le traitement et/ou la prévention et/ou la diminution de la survenance de l’allergie aux pollens et/ou des pathologies et/ou symptômes associées à l’allergie aux pollens.
FR2005179A 2020-05-20 2020-05-20 Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera Active FR3110402B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR2005179A FR3110402B1 (fr) 2020-05-20 2020-05-20 Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera
PCT/FR2021/050899 WO2021234301A1 (fr) 2020-05-20 2021-05-20 Utilisation d'un extrait proteique des graines de moringa oleifera comme agent anti-pollen
JP2022570606A JP2023527160A (ja) 2020-05-20 2021-05-20 モリンガ・オレイフェラ種子タンパク質抽出物の抗花粉剤としての使用
CN202180036930.0A CN115697367A (zh) 2020-05-20 2021-05-20 辣木籽的蛋白质提取物的化妆品用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2005179 2020-05-20
FR2005179A FR3110402B1 (fr) 2020-05-20 2020-05-20 Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera

Publications (2)

Publication Number Publication Date
FR3110402A1 FR3110402A1 (fr) 2021-11-26
FR3110402B1 true FR3110402B1 (fr) 2022-10-28

Family

ID=72644325

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2005179A Active FR3110402B1 (fr) 2020-05-20 2020-05-20 Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera

Country Status (4)

Country Link
JP (1) JP2023527160A (fr)
CN (1) CN115697367A (fr)
FR (1) FR3110402B1 (fr)
WO (1) WO2021234301A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776519B1 (fr) * 1998-03-24 2000-11-17 Serobiologiques Lab Sa Utilisation d'au moins un extrait proteique de graines de plantes du genre moringa et composition cosmetique et/ou pharmaceutique correspondante
FR2825267B1 (fr) 2001-05-29 2009-08-28 Philippe Jean Louis Thurot Compositions pour l'hygiene buccale ou corporelle ou la proprete ou la sante comprenant des graines ou un broyat de graines ou un extrait de graines du genre moringa
JP2009155268A (ja) * 2007-12-27 2009-07-16 Miyoshi Oil & Fat Co Ltd 抗花粉アレルゲン剤
FR2928548B1 (fr) 2008-03-14 2015-07-03 Basf Beauty Care Solutions F Substances augmentant le seuil d'activation des cellules immunes
FR3076460B1 (fr) 2018-01-09 2020-11-13 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait proteique des graines de moringa oleifera

Also Published As

Publication number Publication date
FR3110402A1 (fr) 2021-11-26
JP2023527160A (ja) 2023-06-27
CN115697367A (zh) 2023-02-03
WO2021234301A1 (fr) 2021-11-25

Similar Documents

Publication Publication Date Title
MX2024003316A (es) Anticuerpos de union al supresor de activacion de celulas t que contiene dominio v de inmunoglobina (vista) a ph acido.
MA55434A (fr) Compositions comprenant des souches bactériennes
MA40224B1 (fr) Anticorps se liant aux protofibrilles ass améliorés
MA41010B1 (fr) Compositions comprenant des souches bactériennes
BRPI0708101A8 (pt) anticorpos contra a il-22 humana e usos para eles
FR3076460B1 (fr) Utilisation cosmetique d'un extrait proteique des graines de moringa oleifera
MA30252B1 (fr) Vaccin therapeutique
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
EP2987807A3 (fr) Anticorps dirigés contre tau phosphorylée
DE602005026662D1 (de) Zusammensetzungen, die sich für die behandlung von hautalterungssymptomen eignen
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
MA43113B1 (fr) Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci
EA201170571A1 (ru) Способы и композиции для улучшения когнитивной функции
MA38284B1 (fr) Inhibiteurs de la phospholipase associée aux lipoprotéines a2 (lp-pla2) à base de 2,3-dihydro-imidazol[1,2-c]pyrimidin-5(1 h)-one
MA38638A1 (fr) Marqueurs pour troubles liés à la sphingomyélinase acide et leurs utilisations
MX2021000213A (es) Anticuerpos de union al supresor de activacion de linfocitos t que contiene inmunoglobulina con dominio v (vista) a ph acidico.
MX2022003204A (es) Anticuerpos de union al supresor de activacion de linfocitos t que contiene inmunoglobulina con dominio v (vista) a ph acido.
EA202193038A1 (ru) Антитела против sema3a и их применения для лечения заболеваний глаз
MA49947B1 (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
TNSN08290A1 (fr) Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillissement cutane
FR3110402B1 (fr) Utilisation cosmetique d’un extrait proteique des graines de moringa oleifera
FR2947727B1 (fr) Composition cosmetique a usage topique, trousse en comportant, procede cosmetique modulable en fonction du vieillissement de la peau la mettant en oeuvre
EA201590303A1 (ru) Новый аллерген из пыльцы амброзии и его применение
JOP20200183A1 (ar) جزيء ربط له نشاط تحييد ضد متلازمة الشرق الأوسط التنفسية – فيروس كورونا
MA39406B1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211126

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5